(0.33%) 5 116.93 points
(0.30%) 38 355 points
(0.38%) 15 988 points
(-0.85%) $83.14
(5.77%) $2.03
(0.45%) $2 357.80
(0.47%) $27.67
(3.92%) $958.25
(-0.22%) $0.933
(-0.37%) $10.98
(-0.55%) $0.796
(1.66%) $93.40
@ $51.45
発行日: 15 2月 2024 @ 01:15
リターン: 4.69%
前回のシグナル: 2月 14 - 23:33
前回のシグナル:
リターン: -0.56 %
Live Chart Being Loaded With Signals
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally...
Stats | |
---|---|
本日の出来高 | 249 342 |
平均出来高 | 397 529 |
時価総額 | 1.99B |
EPS | $0 ( 2024-02-28 ) |
次の収益日 | ( $-0.170 ) 2024-05-06 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -38.20 |
ATR14 | $0.107 (0.20%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-01 | Thunen Shelley B | Sell | 8 857 | Common Stock |
2024-04-01 | Thunen Shelley B | Sell | 800 | Common Stock |
2024-04-01 | Thunen Shelley B | Sell | 8 938 | Common Stock |
2024-04-01 | Thunen Shelley B | Sell | 662 | Common Stock |
2024-04-01 | Thunen Shelley B | Sell | 200 | Common Stock |
INSIDER POWER |
---|
5.78 |
Last 100 transactions |
Buy: 649 170 | Sell: 601 875 |
ボリューム 相関
RxSight, Inc. 相関 - 通貨/商品
RxSight, Inc. 財務諸表
Annual | 2023 |
収益: | $89.08M |
総利益: | $53.77M (60.36 %) |
EPS: | $-1.410 |
FY | 2023 |
収益: | $89.08M |
総利益: | $53.77M (60.36 %) |
EPS: | $-1.410 |
FY | 2022 |
収益: | $49.01M |
総利益: | $21.33M (43.52 %) |
EPS: | $-2.41 |
FY | 2021 |
収益: | $22.59M |
総利益: | $4.52M (19.99 %) |
EPS: | $-2.59 |
Financial Reports:
No articles found.
RxSight, Inc.
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。